Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Eli Lilly And Co (LLY)

2014-12-19@11:27:58 ET
Potential Eli Lilly (LLY) Trade Has 2.75% Downside Protection (FBM)

2014-12-19@08:09:35 ET
Lilly to co-develop ultra-rapid insulin BioChaperone Lispro in partnership with Adocia (MTO)

2014-12-19@06:15:58 ET
Diabetic Neuropathic Pain - Pipeline Review, H2 2014 (MTO)

2014-12-19@06:09:03 ET
Hypercholesterolemia - Pipeline Review, H2 2014 (MTO)

2014-12-19@01:30:00 ET
Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology (PRN)

2014-12-18@21:12:41 ET
Eli Lilly & Co.Corporate Event Announcement Notice (WSH)

2014-12-18@17:00:44 ET
Watch for Eli Lilly to Potentially Pullback After Gaining 3.09% Yesterday (PSM)

2014-12-18@17:00:13 ET
SmarTrend Watching for Potential Pullback in Shares of Eli Lilly After 3.09% Gain (PSM)

2014-12-18@11:10:13 ET
Next Resistance Level for Eli Lilly (LLY) is $71.54 (F79)

2014-12-18@10:51:01 ET
Biothera Participates in Cancer Research UK Combinations Alliance (BIZ)

2014-12-18@09:59:04 ET
Morgan Stanley's Rating Change Only Had Short-term Impact, Eli Lilly Down 1.1% (LLY) (F70)

2014-12-18@04:29:58 ET
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:24:42 ET
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:08:11 ET
Myelofibrosis - Pipeline Review, H1 2014 (MTO)

2014-12-18@04:03:02 ET
Mild Cognitive Impairment - Pipeline Review, H1 2014 (MTO)

2014-12-18@03:57:04 ET
Eli Lilly receives FDA approval for non-small cell lung cancer drug (DTM)

2014-12-18@03:44:57 ET
Androgel Testosterone Lawsuit Trials Develop; Coordination Questions Arise (PRW)

2014-12-18@02:11:20 ET
Lilly Declares Dividend (CLM)

2014-12-17@11:33:00 ET
Lilly Sets Dates and Conference Calls for 2015 Financial Guidance and Fourth-Quarter 2014 Financial Results (PRN)

2014-12-17@10:15:38 ET
Eli Lilly (LLY) Showing Support Near $67.56 (FBM)